Form 4: Immunovant CFO Sells Shares to Cover Tax Obligations

Eva Renee Barnett, CFO of Immunovant, Inc., sold 2,814 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On February 19, 2025, Eva Renee Barnett, the Chief Financial Officer of Immunovant, Inc., sold 2,814 shares of Immunovant's common stock.
• The sale was executed at a weighted average price of $20.86 per share, with individual transactions ranging from $20.51 to $21.09.
• This transaction was to cover tax withholding obligations associated with the vesting of 7,051 restricted stock units (RSUs) on February 17, 2025, which were part of a grant of 112,816 RSUs from August 17, 2022.
• The sale was mandated by Immunovant's policy requiring tax obligations to be funded through a 'sell to cover' transaction.
• Following the reported transaction, Barnett directly owns 321,952 shares of Immunovant common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations and does not reflect a change in the executive's outlook on the company.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives. This transaction is not necessarily indicative of the executive's sentiment towards the company's future prospects, but rather a standard procedure to manage tax liabilities.

Comparison to Industry Standards

• The 'sell to cover' practice is widely used across the industry, including companies like Amgen, Regeneron, and Biogen, to manage tax obligations related to equity compensation.
• Executive compensation packages often include RSUs, and the subsequent tax implications are typically handled through similar mechanisms.
• The weighted average price of $20.86 per share is within the typical range observed for Immunovant's stock during the period, reflecting market conditions.

Stakeholder Impact

• The sale of shares may have a minor, temporary impact on the stock price, but is unlikely to significantly affect long-term shareholder value.
• Employees holding RSUs may experience similar tax obligations upon vesting.

Key Dates

Keywords

Immunovant, IMVT, Eva Renee Barnett, CFO, Form 4, Share Sale, Restricted Stock Units, Tax Withholding, Sell to Cover, Beneficial Ownership